In uncontrolled clinical trials of ebimar, Bonfils and Lambling (1960b) treated 32 peptic ulcer patients who had failed to respond to other medicinal therapy. They were impressed with the results and so were Lambling, Bonfils, Kaess and Simonpoli (1960) , who followed patients for up to 18 months. Both these papers emphasise the importance of dosage and the frequency of administration of the substance. Berthet (1961) , Esposito (1962) and de Landazuri, Badell and Badell and Conchillo (1961) also reported favourably on ebimar. The latter advocate sucking the tablets. Esposito and Nicolini (1961) showed that in patients with a raised blood pepsinogen ebimar caused a return towards normal levels. Fig. 1 hydroxide, but these differences were again not significant. The conclusion therefore is that there was some radiological evidence in favour of aluminium hydroxide after 5 months of treatment 
Summary
In two blind trials of degraded carrageenin (Ebimar) and aluminium hydroxide gel in the treatment of peptic ulceration, using different dose schedules in the two trials, degraded carrageenin and aluminium hydroxide both appeared to be effective in giving symptomatic relief but neither seemed to influence the natural history of the diseases.
